Andrew S. Boyer - Aug 11, 2023 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Denis Butkovic, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Aug 11, 2023
Transactions value $
-$120,921
Form type
4
Date filed
8/15/2023, 04:30 PM
Previous filing
Jul 5, 2023
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Sale -$121K -29.3K -10.69% $4.13 245K Aug 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.22, inclusive. The reporting person undertakes to provide to Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.